\SKN[Anti-AGinG PePtiDes
\TRM[dermaPep™\] a350 (tripeptide)  

\TRM[dermaPep™\] a420 (tetrapeptide)

Anti-infLAMMAtORy PePtiDe
\TRM[dermaPep™\] a530 (Pentapeptide) 

seLf-tAnninG PePtiDe
\TRM[dermaPep™\] t430 (tetrapeptide)

WHiteninG PePtiDes
\TRM[dermaPep™\] W220 (dipeptide) 

\TRM[dermaPep™\] W411 (Hexapeptide)

\TRM[dermaPep™\] Ul

FEatURIng \TRM[dERMaPEP™\] a350

tARGeteD Anti-AGinG sOLUtiOn 
\CLA[\SUB[tripeptide\] designed to address wrinkle formation, inflammation and uneven complexion associated with aging.

Helps create a smoother, more youthful appearance\].

\PRT|VIV[Clinical studies involved \NUM[30\] females testing \TRM[DermaPep™\] A350 on \BOP[outer eye area\] \USF[twice daily\] for \DUR[12 weeks\]\]. 

AntI-wRInkle ReSultS SkIn lIghtenIng ReSultS

Pe
rc

en
t (

%
) I

m
p

ro
ve

m
en

t

0 4

35
33

30

Weeks

Wrinkle area Wrinkle lengthWrinkle number

0

10

20

30

40

L (luminosity) = 0 to 100 (black to white)

Days

0

0.5

1

1.5

2

D28

0.8

D56

1.1

D84

1.8

D0

0

 Im
p

ro
ve

m
en

t (
∆

L*
 v

al
ue

)\]